IRCT20220910055934N1招募中3 期
Evaluation of empagliflozin on diastolic function in prediabetic people with body mass index>30 kg/m2 Imam Hossein Hospital
适应症
试验速览
- 阶段
- 3 期
- 状态
- 招募中
- 入组人数
- 39
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 18 years 至 no limit（—）
- 性别
- All
入选标准
- •age more than 18 years old
- •prediabetic (100BMI more than 30 kg/m2
- •stability in cardiac symptom in the last 3 months
排除标准
- •Using empagliflozin during the last 3 months
研究者
相似试验
招募中
3 期
?Effect of Empagliflozin in ?heart failure preserved ejection fractioIRCT20190122042450N2Abidi pharmacy200
招募中
不适用
Efficacy of empagliflozin on diastolic dysfunction during exercise stress echocardiography in patients with heart failure with preserved ejection fraction Prospective open-label randomized parallel-group studyHeart failure with preserved ejection fracitonJPRN-UMIN000048016Mitsui Memorial Hospital52
尚未招募
3 期
Effect of Empagliflozin as adjunctive therapy on serum level of oxidative stress biomarkersIRCT20120215009014N486Hamedan University of Medical Sciences80
进行中（未招募）
1 期
Effect of Empagliflozin on Cardiac Output in Patients with Acute Heart Failure (EMPA Acute Heart Failure)EUCTR2017-002695-45-DERWTH Aachen University represented by the Rector, himself, represented by the Dean of the Medical Faculty50
已完成
1 期
Empagliflozin in non alcoholic fatty liverDiabetic patient with non alcoholic fatty liver.Other specified inflammatory liver diseasesK75.8IRCT20150706023084N18Islamic Azad University30